Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 7Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 5Pain, Postoperative 2Neoplasms 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Stomach Neoplasms 1Papillomavirus Infections 1Lymphoma 1Leukemia 1Infections 1Hyperglycemia 1Gastrostomy 1Chronic Pain 1Brain Neoplasms 1Attention Deficit Disorder with Hyperactivity 1

Interventions

Gastrectomy 13Observation 12Gastroscopy 11Drug Therapy 9Surveys and Questionnaires 8Surgical Procedures, Operative 8Endoscopic Mucosal Resection 8Paclitaxel 6Immune Checkpoint Inhibitors 6Blood Specimen Collection 6Tomography, X-Ray Computed 5Oxaliplatin 5Trastuzumab 4Ramucirumab 4Irinotecan 4Immunotherapy 4Hyperthermic Intraperitoneal Chemotherapy 4Cisplatin 4Biopsy 4tislelizumab 3S 1 (combination) 3Robotic Surgical Procedures 3Radiotherapy 3Positron Emission Tomography Computed Tomography 3Nivolumab 3Neoadjuvant Therapy 3Laparoscopy 3Interviews as Topic 3Capecitabine 3taxane 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Stomach Neoplasms × Control Groups × Clear all
NCT06317103 2024-03-19

A Clinical Trial to Evaluate the Sensitivity and Specificity of "WAYMED Endo" Compared to the Endoscopists in Classifying Early Gastric Cancer (EGC) Based on the Depth of Invasion in Endoscopic Images

WAYCEN Inc

Completed
653 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡